Emerging Role of Relaxin in the Maternal Adaptations to Normal Pregnancy: Implications for Preeclampsia

Seminars in Nephrology

Volumn 31, Issue 1, 2011, Pages 15-32

  Conrad, Kirk P ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

Angiogenic growth factors; Artery; Decidualization; Endothelin; Matrix metalloproteinases; Nitric oxide; Placenta; Renal circulation; Trophoblast

Indexed keywords

ANGIOGENIC FACTOR; BIG ENDOTHELIN 1; ENDOTHELIAL NITRIC OXIDE SYNTHASE; ENDOTHELIN B RECEPTOR; GELATINASE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; PHOSPHATIDYLINOSITOL 3 KINASE; PLACENTAL GROWTH FACTOR; PROTEIN KINASE B; RELAXIN; VASCULOTROPIN;

ADAPTATION; ARTERY COMPLIANCE; ARTICLE; BLOOD PRESSURE MONITORING; CORONARY ARTERY DILATATION; COUPLING FACTOR; DECIDUALIZATION; DISEASE SEVERITY; ELIMINATION REACTION; ENZYME ACTIVITY; GLOMERULUS FILTRATION; GLOMERULUS FILTRATION RATE; HEART OUTPUT; HUMAN; KIDNEY FUNCTION; KIDNEY PLASMA FLOW; NONHUMAN; OSMOTIC PUMP; PREECLAMPSIA; PREGNANCY; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; SECOND TRIMESTER PREGNANCY; SYSTEMIC VASCULAR RESISTANCE; TROPHOBLAST;

ADAPTATION, PHYSIOLOGICAL; ANIMALS; FEMALE; HEMODYNAMICS; HUMANS; MODELS, ANIMAL; PRE-ECLAMPSIA; PREGNANCY; RELAXIN; VASODILATION;

EID: 78751699508     PISSN: 02709295     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.semnephrol.2010.10.003     Document Type: Article

References (131)

1. Sherwood O.D. Relaxin. The physiology of reproduction 1994, 861-1008. Raven Press, New York. E. Knobil, J.D. Neill, G.S. Greenwald, C.L. Markert, D.W. Pfaff (Eds.).
2. Kohsaka T., Min G., Lukas G., Trupin S., Campbell E.T., Sherwood O.D. Identification of specific relaxin-binding cells in the human female. Biol Reprod 1998, 59:991-999.
3. Novak J., Parry L.J., Matthews J.E., Kerchner L.J., Indovina K., Hanley-Yanez K., et al. Evidence for local relaxin ligand-receptor expression and function in arteries. FASEB J 2006, 20:2352-2362.
4. Hisaw F.L. Experimental relaxation of the public ligament of the guinea pig. Proc Exp Biol Med 1926, 23:661-663.
5. Ziel H.K., Swain C.T., Frederick L. Hisaw and the discovery of relaxin. Endocrinologist 2000, 10:215-218.
6. Dallenbach-Hellweg G., Dawson A.B., Hisaw F.L. The effect of relaxin on the endometrium of monkeys. Histological and histochemical studies. Am J Anat 1966, 119:61-78.
7. Hisaw F.L., Hisaw F.L., Dawson A.B. Effects of relaxin on the endothelium of endometrial blood vessels in monkeys (Macaca mulatta). Endocrinology 1967, 81:375-385.
8. Conrad K.P., Novak J. The emerging role of relaxin in renal and cardiovascular function. Am J Physiol Regul Integr Comp Physiol 2004, 287:R250-R261.
9. Jeyabalan A., Shroff S.G., Novak J., Conrad K.P. The vascular actions of relaxin. Adv Exp Med Biol 2007, 612:65-87.
10. St-Louis J., Massicotte G. Chronic decrease of blood pressure by rat relaxin in spontaneously hypertensive rats. Life Sci 1985, 37:1351-1357.
11. Massicotte G., Parent A., St-Louis J. Blunted responses to vasoconstrictors in mesenteric vasculature but not in portal vein of spontaneously hypertensive rats treated with relaxin. Proc Soc Exp Biol Med 1989, 190:254-259.
12. Ahokas R.A., Sabai B.M., Anderson G.D. Lack of evidence of a vasodepressor role for relaxin in spontaneously hypertensive and normotensive pregnant rats. Am J Obstet Gynecol 1989, 161:618-622.
13. Bani-Sacchi T., Bigazzi M., Bani D., Mannaioni P.F., Masini E. Relaxin-induced increased coronary flow through stimulation of nitric oxide production. Br J Pharmacol 1995, 116:1589-1594.
14. Jeyabalan A., Conrad K.P. Renal physiology and pathophysiology in pregnancy. Renal and electrolyte disorders 2010, 462-518. Lippincott Williams & Wilkins, Philadelphia. R.W. Schrier (Ed.).
15. Gilson G.J., Mosher M.D., Conrad K.P. Systemic hemodynamics and oxygen transport during pregnancy in chronically instrumented, conscious rats. Am J Physiol 1992, 263:H1911-H1918.
16. Slangen B.F., Out I.C., Verkeste C.M., Peeters L.L. Hemodynamic changes in early pregnancy in chronically instrumented, conscious rats. Am J Physiol 1996, 270:H1779-H1784.
17. Spaanderman M.E., Meertens M., van Bussel M., Ekhart T.H., Peeters L.L. Cardiac output increases independently of basal metabolic rate in early human pregnancy. Am J Physiol 2000, 278:H1585-H1588.
18. Bader N.W., Bader M.E., Rose D.J., Braunwald E. Hemodynamics at rest and during exercise in normal pregnancy as studied by cardiac catheterization. J Clin Invest 1955, 34:1524-1536.
19. Chapman A.B., Zamudio S., Woodmansee W., Merouani A., Osorio F., Johnson A., et al. Systemic and renal hemodynamic changes in the luteal phase of the menstrual cycle mimic early pregnancy. Am J Physiol 1997, 273:F777-F782.
20. Poppas A., Shroff S.G., Korcarz C.E., Hibbard J.U., Berger D.S., Lindheimer M.D., et al. Serial assessment of the cardiovascular system in normal pregnancy. Role of arterial compliance and pulsatile arterial load. Circulation 1997, 95:2407-2415.
21. Robb A.O., Mills N.L., Din J.N., Smith I.B., Paterson F., Newby D.E., et al. Influence of the menstrual cycle, pregnancy, and preeclampsia on arterial stiffness. Hypertension 2009, 53:952-958.
22. Debrah D.O., Novak J., Matthews J.E., Ramirez R.J., Shroff S.G., Conrad K.P. Relaxin is essential for systemic vasodilation and increased global arterial compliance during early pregnancy in conscious rats. Endocrinology 2006, 147:5126-5131.
23. Conrad K.P., Debrah D.O., Novak J., Danielson L.A., Shroff S.G. Relaxin modifies systemic arterial resistance and compliance in conscious, nonpregnant rats. Endocrinology 2004, 145:3289-3296.
24. Conrad K.P., Gaber L.W., Lindheimer M. The kidney in normal pregnancy and preeclampsia. Chesley's hypertensive disorders in pregnancy 2009, 297-334. Elsevier (Academic Press), San Diego. M. Lindheimer, J.M. Roberts, F.G. Cunningham (Eds.).
25. Conrad K.P. Mechanisms of renal vasodilation and hyperfiltration during pregnancy. J Soc Gynecol Invest 2004, 11:438-448.
26. Conrad K.P. Renal hemodynamics during pregnancy in chronically catheterized, conscious rats. Kidney Int 1984, 26:24-29.
27. Debrah D.O., Conrad K.P., Danielson L.A., Shroff S.G. Effects of relaxin on systemic arterial hemodynamics and mechanical properties in conscious rats: sex dependency and dose response. J Appl Physiol 2005, 98:1013-1020.
28. Debrah D.O., Conrad K.P., Jeyabalan A., Danielson L.A., Shroff S.G. Relaxin increases cardiac output and reduces systemic arterial load in hypertensive rats. Hypertension 2005, 46:745-750.
29. Dschietzig T., Teichman S., Unemori E., Wood S., Boehmer J., Richter C., et al. Intravenous recombinant human relaxin in compensated heart failure: a safety, tolerability, and pharmacodynamic trial. J Card Fail 2009, 15:182-190.
30. Shroff S.G., Berger D.S., Korcarz C., Lang R.M., Marcus R.H., Miller D.E. Physiological relevance of T-tube model parameters with emphasis on arterial compliances. Am J Physiol 1995, 269:H365-H374.
31. McGuane J.T., Debrah J.E., Debrah D.O., Rubin J.P., Segal M.S., Shroff S.G., et al. Role of relaxin in maternal systemic and renal vascular adapations during gestation. Ann N Y Acad Sci 2009, 1160:304-312.
32. Danielson L.A., Sherwood O.D., Conrad K.P. Relaxin is a potent renal vasodilator in conscious rats. J Clin Invest 1999, 103:525-533.
33. Danielson L.A., Kercher L.J., Conrad K.P. Impact of gender and endothelin on renal vasodilation and hyperfiltration induced by relaxin in conscious rats. Am J Physiol Regul Integr Comp Physiol 2000, 279:R1298-R1304.
34. Conrad K.P., Colpoys M.C. Evidence against the hypothesis that prostaglandins are the vasodepressor agents of pregnancy. Serial studies in chronically instrumented, conscious rats. J Clin Invest 1986, 77:236-245.
35. Danielson L.A., Conrad K.P. Acute blockade of nitric oxide synthase inhibits renal vasodilation and hyperfiltration during pregnancy in chronically instrumented conscious rats. J Clin Invest 1995, 96:482-490.
36. Novak J., Reckelhoff J., Bumgarner L., Cockrell K., Kassab S., Granger J.P. Reduced sensitivity of the renal circulation to angiotensin II in pregnant rats. Hypertension 1997, 30:580-584.
37. Bogzil A.H., Eardley R., Ashton N. Relaxin-induced changes in renal sodium excretion in the anesthetized male rat. Am J Physiol 2005, 288:R322-R328.
38. Novak J., Ramirez R.J., Gandley R.E., Sherwood O.D., Conrad K.P. Myogenic reactivity is reduced in small renal arteries isolated from relaxin-treated rats. Am J Physiol Regul Integr Comp Physiol 2002, 283:R349-R355.
39. Gandley R.E., Conrad K.P., McLaughlin M.K. Endothelin and nitric oxide mediate reduced myogenic reactivity of small renal arteries from pregnant rats. Am J Physiol Regul Integr Comp Physiol 2001, 280:R1-R7.
40. Danielson L.A., Conrad K.P. Time course and dose response of relaxin-mediated renal vasodilation, hyperfiltration, and changes in plasma osmolality in conscious rats. J Appl Physiol 2003, 95:1509-1514.
41. Smith M.C., Danielson L.A., Conrad K.P., Davison J.M. Influence of recombinant human relaxin on renal hemodynamics in healthy volunteers. J Am Soc Nephrol 2006, 17:3192-3197.
42. Erikson M.S., Unemori E.N. Relaxin clinical trials in systemic sclerosis. In: Relaxin 2000: proceedings of the third international conference on relaxin and related peptides 2000, Kulwer Academic Publishers, Dordrecht, The Netherlands.
43. Khanna D., Clements P.J., Furst D.E., Korn J.H., Ellman M., Rothfield N., et al. Recombinant human relaxin in the treatment of systemic sclerosis with diffuse cutaneous involvement: a randomized, double-blind, placebo-controlled trial. Arthritis Rheum 2009, 60:1102-1111.
44. Novak J., Danielson L.A., Kerchner L.J., Sherwood O.D., Ramirez R.J., Moalli P.A., et al. Relaxin is essential for renal vasodilation during pregnancy in conscious rats. J Clin Invest 2001, 107:1469-1475.
45. Smith M.C., Murdoch A.P., Danielson L.A., Conrad K.P., Davison J.M. Relaxin has a role in establishing a renal response in pregnancy. Fertil Steril 2006, 86:253-255.
46. Conrad K. Possible mechanisms for changes in renal hemodynamics during pregnancy: studies from animal models. Am J Kidney Dis 1987, 9:253-259.
47. Conrad K.P., Vernier K.A. Plasma level, urinary excretion, and metabolic production of cGMP during gestation in rats. Am J Physiol 1989, 257:R847-R853.
48. Conrad K.P., Kerchner L.J., Mosher M.D. Plasma and 24-h NO(x) and cGMP during normal pregnancy and preeclampsia in women on a reduced NO(x) diet. Am J Physiol 1999, 277:F48-F57.
49. Kopp L., Paradiz G., Tucci J. Urinary excretion of cyclic 3', 5' -adenosine monophosphate and cyclic 3', 5' -guanosine monophosphate during and after pregnancy. J Clin Endocrinol Metab 1977, 44:590-594.
50. Sala C., Campise M., Ambroso G., Motta T., Zanchetti A., Morganti A. Atrial natriuretic peptide and hemodynamics changes during normal human pregnancy. Hypertension 1995, 25:631-636.
51. Palmer R.M., Ferrige A.G., Moncada S. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 1987, 327:524-526.
52. Conrad K.P., Joffe G.M., Kruszyna H., Kruszyna R., Rochelle L.G., Smith R.P., et al. Identification of increased nitric oxide biosynthesis during pregnancy in rats. FASEB J 1993, 7:566-571.
53. Lubarsky S.L., Ahokas R.A., Friedman S.A., Sibai B.M. The effect of chronic nitric oxide synthesis inhibition on blood pressure and angiotensin II responsiveness in the pregnant rat. Am J Obstet Gynecol 1997, 176:1069-1076.
54. Deng A., Engels K., Baylis C. Impact of nitric oxide deficiency on blood pressure and glomerular hemodynamic adaptations to pregnancy in the rat. Kidney Int 1996, 50:1132-1138.
55. Yang D., Lang U., Greenberg S.G., Myatt L., Clark K.E. Elevation of nitrate levels in pregnant ewes and their fetuses. Am J Obstet Gynecol 1996, 174:573-577.
56. Baylis C., Suto T., Conrad K. Importance of nitric oxide in control of systemic and renal hemodynamics during normal pregnancy: studies in the rat implications for preeclampsia. Hypertens Pregnancy 1996, 15:147-169.
57. Sladek S.M., Magness R.R., Conrad K.P. Nitric oxide and pregnancy. Am J Physiol 1997, 272:R441-R463.
58. Lopez-Jaramillo P., Arenas W.D., Garcia R.G., Rincon M.Y., Lopez M. The role of the L-arginine-nitric oxide pathway in preeclampsia. Ther Adv Cardiovasc Dis 2008, 2:261-275.
59. Cadnapaphornchai M.A., Ohara M., Morris K.G., Knotek M., Rogachev B., Ladtkow T., et al. Chronic NOS inhibition reverses systemic vasodilation and glomerular hyperfiltration in pregnancy. Am J Physiol 2001, 280:F592-F598.
60. Baylis C., Engels K. Adverse interactions between pregnancy and a new model of systemic hypertension produced by chronic blockade of endothelial derived relaxing factor (EDRF) in the rat. Clin Exp Hypertens Pregnancy 1992, B11:117-129.
61. Danielson L.A., Conrad K.P. Prostaglandins maintain renal vasodilation and hyperfiltration during chronic nitric oxide synthase blockade in conscious pregnant rats. Circ Res 1996, 79:1161-1166.
62. Williams D.J., Vallance P.J., Neild G.H., Spencer J.A., Imms F.J. Nitric oxide-mediated vasodilation in human pregnancy. Am J Physiol 1997, 272:H748-H752.
63. Anumba D.O., Robson S.C., Boys R.J., Ford G.A. Nitric oxide activity in the peripheral vasculature during normotensive and preeclamptic pregnancy. Am J Physiol 1999, 277:H848-H854.
64. Novak J., Rajakumar A., Miles T.M., Conrad K.P. Nitric oxide synthase isoforms in the rat kidney during pregnancy. J Soc Gynecol Investig 2004, 11:280-288.
65. Alexander B.T., Miller M.T., Kassab S., Novak J., Reckelhoff J.F., Kruckeberg W.C., et al. Differential expression of renal nitric oxide synthase isoforms during pregnancy in rats. Hypertension 1999, 33:435-439.
66. Conrad K.P., Gandley R.E., Ogawa T., Nakanishi S., Danielson L.A. Endothelin mediates renal vasodilation and hyperfiltration during pregnancy in chronically instrumented conscious rats. Am J Physiol 1999, 276:F767-F776.
67. Dschietzig T., Bartsch C., Richter C., Laule M., Baumann G., Stangl K. Relaxin, a pregnancy hormone, is a functional endothelin-1 antagonist: attenuation of endothelin-1-mediated vasoconstriction by stimulation of endothelin type-B receptor expression via ERK-1/2 and nuclear factor-kappaB. Circ Res 2003, 92:32-40.
68. Kerchner L.J., Novak J., Hanley-Yanez K., Doty K.D., Danielson L.A., Conrad K.P. Evidence against the hypothesis that endothelial endothelin B receptor expression is regulated by relaxin and pregnancy. Endocrinology 2005, 146:2791-2797.
69. Fernandez-Patron C., Radomski M.W., Davidge S.T. Vascular matrix metalloproteinase-2 cleaves big endothelin-1 yielding a novel vasoconstrictor. Circ Res 1999, 85:906-911.
70. Jeyabalan A., Novak J., Danielson L.A., Kerchner L.J., Opett S.L., Conrad K.P. Essential role for vascular gelatinase activity in relaxin-induced renal vasodilation, hyperfiltration, and reduced myogenic reactivity of small arteries. Circ Res 2003, 93:1249-1257.
71. Jeyabalan A., Novak J., Doty K.D., Matthews J., Fisher M.C., Kerchner L.J., et al. Vascular matrix metalloproteinase-9 mediates the inhibition of myogenic reactivity in small arteries isolated from rats after short-term administration of relaxin. Endocrinology 2007, 148:189-197.
72. Jeyabalan A., Kerchner L.J., Fisher M.C., McGuane J.T., Doty K.D., Conrad K.P. Matrix metalloproteinase-2 activity, protein, mRNA, and tissue inhibitors in small arteries from pregnant and relaxin-treated nonpregnant rats. J Appl Physiol 2006, 100:1955-1963.
73. Koivunen E., Arap W., Valtanen H., Rainisalo A., Medina O.P., Heikkila P., et al. Tumor targeting with a selective gelatinase inhibitor. Nat Biotechnol 1999, 17:768-774.
74. Galardy R.E., Cassabonne M.E., Giese C., Gilbert J.H., Lapierre F., Lopez H., et al. Low molecular weight inhibitors in corneal ulceration. Ann N Y Acad Sci 1994, 732:315-323.
75. Kelly B.A., Bond B.C., Poston L. Aortic adaptation to pregnancy: elevated expression of matrix metalloproteinases-2 and -3 in rat gestation. Mol Hum Reprod 2004, 10:331-337.
76. Danielson L.A., Welford A., Harris A. Relaxin improves renal function and histology in aging Munich Wistar rats. J Am Soc Nephrol 2006, 17:1325-1333.
77. van Eijndhoven H.W., Janssen G.M., Aardenburg R., Spaanderman M.E., Peeters L.L., De Mey J.G. Mechanisms leading to increased vasodilator responses to calcitonin-gene-related peptide in mesenteric resistance arteries of early pregnant rats. J Vasc Res 2008, 45:350-356.
78. Novak J., Conrad K.P. Small renal arteries isolated from ETB receptor deficient rats fail to exhibit the normal maternal adaptation to pregnancy [abstract]. FASEB J 2004, 18:32.
79. Debrah J.E., Agoulnik A., Conrad K.P. Changes in arterial function by chronic relaxin infusion are mediated by the leucine rich repeat G coupled Lgr7 receptor [abstract]. Reprod Sci 2008, 15. Suppl:217A.
80. Debrah J.E., McGuane J.T., Novak J., Rubin J.P., Conrad K.P. Vascular endothelial and placental growth factors: new players in the slow relaxin vasodilatory pathway. Ann N Y Acad Sci 2009, 1160:304-312.
81. Danielson L.A., McGuane J.T., Debrah J.E., Conrad K.P. Relaxin-induced renal vasodilation and hyperfiltration are mediated by vascular endothelial growth factor receptor(s) in chronically-instrumented, conscious rats [abstract]. Reprod Sci 2010, 11:357.
82. Fisher C., MacLean M., Morecroft I., Seed A., Johnston F., Hillier C., et al. Is the pregnancy hormone relaxin also a vasodilator peptide secreted by the heart? Circulation 2002, 106:292-295.
83. McGuane J.T., Sautina L., Debrah J.E., Segal M.S., Conrad K.P. Mechanisms of relaxin-induced rapid arterial relaxation [abstract]. Reprod Sci 2009, 16:106A.
84. Brosens J.J., Pijnenborg R., Brosens I.A. The myometrial junctional zone spiral arteries in normal and abnormal pregnancies: a review of the literature. Am J Obstet Gynecol 2002, 187:1416-1423.
85. Burton G.J., Woods A.W., Jauniaux E., Kingdom J.C. Rheological and physiological consequences of conversion of the maternal spiral arteries for uteroplacental blood flow during human pregnancy. Placenta 2009, 30:473-482.
86. Red-Horse K., Rivera J., Schanz A., Zhou Y., Winn V., Kapidzic M., et al. Cytotrophoblast induction of arterial apoptosis and lymphangiogenesis in an in vivo model of human placentation. J Clin Invest 2006, 116:2643-2652.
87. Whitley G.S., Cartwright J.E. Trophoblast-mediated spiral artery remodelling: a role for apoptosis. J Anat 2009, 215:21-26.
88. Harris L.K. Review: trophoblast-vascular cell interactions in early pregnancy: how to remodel a vessel. Placenta 2010, 31. Suppl:S93-8.
89. DiFederico E., Genbacev O., Fisher S.J. Preeclampsia is associated with widespread apoptosis of placental cytotrophoblasts within the uterine wall. Am J Pathol 1999, 155:293-301.
90. Fisher S.J., McMaster M., Roberts J.M. The placenta in normal pregnancy and preeclampsia. Chesley's hypertensive disorders in pregnancy 2009, 73-86. Academic Press, San Diego. M.D. Lindheimer, J.M. Roberts, F.G. Cunningham (Eds.).
91. Knofler M. Critical growth factors and signalling pathways controlling human trophoblast invasion. Int J Dev Biol 2010, 54:269-280.
92. Shore V.H., Wang T.H., Wang C.L., Torry R.J., Caudle M.R., Torry D.S. Vascular endothelial growth factor, placenta growth factor and their receptors in isolated human trophoblast. Placenta 1997, 18:657-665.
93. Fisher S.J., Damsky C.H. Human cytotrophoblast invasion. Semin Cell Biol 1993, 4:183-188.
94. Maruo N., Nakabayashi K., Wakahashi S., Yata A., Maruo T. Effects of recombinant H2 relaxin on the expression of matrix metalloproteinases and tissue inhibitor metalloproteinase in cultured early placental extravillous trophoblasts. Endocrine 2007, 32:303-310.
95. Goligorsky M.S., Budzikowski A.S., Tsukahara H., Noiri E. Co-operation between endothelin and nitric oxide in promoting endothelial cell migration and angiogenesis. Clin Exp Pharmacol Physiol 1999, 26:269-271.
96. Martin D., Conrad K.P. Expression of endothelial nitric oxide synthase by extravillous trophoblast cells in the human placenta. Placenta 2000, 21:23-31.
97. Cervar M., Puerstner P., Kainer F., Desoye G. Endothelin-1 stimulates the proliferation and invasion of first trimester trophoblastic cells in vitro-a possible role in the etiology of pre-eclampsia? J Investig Med 1996, 44:447-453.
98. Chakraborty C., Barbin Y.P., Chakrabarti S., Chidiac P., Dixon S.J., Lala P.K. Endothelin-1 promotes migration and induces elevation of [Ca2+]i and phosphorylation of MAP kinase of a human extravillous trophoblast cell line. Mol Cell Endocrinol 2003, 201:63-73.
99. Gellersen B., Brosens I.A., Brosens J.J. Decidualization of the human endometrium: mechanisms, functions, and clinical perspectives. Semin Reprod Med 2007, 25:445-453.
100. Founds S.A., Conley Y.P., Lyons-Weiler J.F., Jeyabalan A., Hogge W.A., Conrad K.P. Altered global gene expression in first trimester placentas of women destined to develop preeclampsia. Placenta 2009, 30:15-24.
101. Goldsmith L.T., Weiss G., Palejwala S., Plant T.M., Wojtczuk A., Lambert W.C., et al. Relaxin regulation of endometrial structure and function in the rhesus monkey. Proc Natl Acad Sci U S A 2004, 101:4685-4689.
102. Hayes E.S. Biology of primate relaxin: a paracrine signal in early pregnancy? Reprod Biol Endocrinol 2004, 2:36.
103. Goldsmith L.T., Weiss G. Relaxin in human pregnancy. Ann N Y Acad Sci 2009, 1160:130-135.
104. Unemori E.N., Erikson M.E., Rocco S.E., Sutherland K.M., Parsell D.A., Mak J., et al. Relaxin stimulates expression of vascular endothelial growth factor in normal human endometrial cells in vitro and is associated with menometrorrhagia in women. Hum Reprod 1999, 14:800-806.
105. Jeyabalan A., Stewart D.R., McGonigal S.C., Powers R.W., Conrad K.P. Low relaxin concentrations in the first trimester are associated with increased risk of developing preeclampsia [abstract]. Reproductive Sci 2009, 16:101A.
106. Kalra S.K., Molinaro T.A. The association of in vitro fertilization and perinatal morbidity. Semin Reprod Med 2008, 26:423-435.
107. Page E.W. The relation between hydatid moles, relative ischemia of the gravid uterus, and the placental origin of eclampsia. Am J Obstet Gynecol 1939, 37:291-293.
108. Rajakumar A., Jeyabalan A., Markovic N., Ness R., Gilmour C., Conrad K.P. Placental HIF-1 alpha, HIF-2 alpha, membrane and soluble VEGF receptor-1 proteins are not increased in normotensive pregnancies complicated by late-onset intrauterine growth restriction. Am J Physiol 2007, 293:R766-R774.
109. Redman C.W., Sargent I.L. Placental stress and pre-eclampsia: a revised view. Placenta 2009, 30. Suppl A:S38-42.
110. Rajakumar A., Whitelock K.A., Weissfeld L.A., Daftary A.R., Markovic N., Conrad K.P. Selective overexpression of the hypoxia-inducible transcription factor, HIF-2alpha, in placentas from women with preeclampsia (erratum: Biol Reprod. 2001;64:1019-20). Biol Reprod 2001, 64:499-506.
111. Redman C.W., Sargent I.L. Microparticles and immunomodulation in pregnancy and pre-eclampsia. J Reprod Immunol 2007, 76:61-67.
112. Redman C.W., Sargent I.L. Latest advances in understanding preeclampsia. Science 2005, 308:1592-1594.
113. Parry L.J., Vodstrcil L.A. Relaxin physiology in the female reproductive tract during pregnancy. Adv Exp Med Biol 2007, 612:34-48.
114. Jauniaux E., Johnson M.R., Jurkovic D., Ramsay B., Campbell S., Meuris S. The role of relaxin in the development of the uteroplacental circulation in early pregnancy. Obstet Gynecol 1994, 84:338-342.
115. Anumba D.O., El Gelany S., Elliott S.L., Li T.C. Serum relaxin levels are reduced in pregnant women with a history of recurrent miscarriage, and correlate with maternal uterine artery Doppler indices in first trimester. Eur J Obstet Gynecol Reprod Biol 2009, 147:41-45.
116. Yao L., Agoulnik A.I., Cooke P.S., Meling D.D., Sherwood O.D. Relaxin acts on stromal cells to promote epithelial and stromal proliferation and inhibit apoptosis in the mouse cervix and vagina. Endocrinology 2008, 149:2072-2079.
117. DiFederico E., Genbacev O., Fisher S.J. Preeclampsia is associated with widespread apoptosis of placental cytotrophoblasts within the uterine wall. Am J Pathol 1999, 155:293-301.
118. Gammill H.S., Roberts J.M. Emerging concepts in preeclampsia investigation. Front Biosci 2007, 12:2403-2411.
119. Maynard S.E., Min J.Y., Merchan J., Lim K.H., Li J., Mondal S., et al. Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J Clin Invest 2003, 111:649-658.
120. Wallukat G., Homuth V., Fischer T., Lindschau C., Horstkamp B., Jupner A., et al. Patients with preeclampsia develop agonistic autoantibodies against the angiotensin AT1 receptor. J Clin Invest 1999, 103:945-952.
121. Rajakumar A., Michael H.M., Rajakumar P.A., Shibata E., Hubel C.A., Karumanchi S.A., et al. Extra-placental expression of vascular endothelial growth factor receptor-1, (Flt-1) and soluble Flt-1 (sFlt-1), by peripheral blood mononuclear cells (PBMCs) in normotensive and preeclamptic pregnant women. Placenta 2005, 26:563-573.
122. Benyo D.F., Smarason A., Redman C.W., Sims C., Conrad K.P. Expression of inflammatory cytokines in placentas from women with preeclampsia. J Clin Endocrinol Metab 2001, 86:2505-2512.
123. Rajakumar A., Brandon H.M., Daftary A., Ness R., Conrad K.P. Evidence for the functional activity of hypoxia-inducible transcription factors overexpressed in preeclamptic placentae. Placenta 2004, 25:763-769.
124. Levine R.J., Maynard S.E., Qian C., Lim K.H., England L.J., Yu K.F., et al. Circulating angiogenic factors and the risk of preeclampsia. N Engl J Med 2004, 350:672-683.
125. Powers R.W., Roberts J.M., Cooper K.M., Gallaher M.J., Frank M.P., Harger G.F., et al. Maternal serum soluble fms-like tyrosine kinase 1 concentrations are not increased in early pregnancy and decrease more slowly postpartum in women who develop preeclampsia. Am J Obstet Gynecol 2005, 193:185-191.
126. Szlachter B.N., Quagliarello J., Jewelewicz R., Osathanondh R., Spellacy W.N., Weiss G. Relaxin in normal and pathogenic pregnancies. Obstet Gynecol 1982, 59:167-170.
127. Scott D.J., Layfield S., Yan Y., Sudo S., Hsueh A.J., Tregear G.W., et al. Characterization of novel splice variants of LGR7 and LGR8 reveals that receptor signaling is mediated by their unique low density lipoprotein class A modules. J Biol Chem 2006, 281:34942-34954.
128. Kern A., Bryant-Greenwood G.D. Mechanisms of relaxin receptor (LGR7/RXFP1) expression and function. Ann N Y Acad Sci 2009, 1160:60-66.
129. Shaul P.W. Regulation of endothelial nitric oxide synthase: location, location, location. Annu Rev Physiol 2002, 64:749-774.
130. Narumiya H., Zhang Y., Fernandez-Patron C., Guilbert L.J., Davidge S.T. Matrix metalloproteinase-2 is elevated in the plasma of women with preeclampsia. Hypertens Pregnancy 2001, 20:185-194.
131. Debrah J.E., McGuane J.T., Novak J., Rubin J.P., Conrad K.P. Vascular endothelial and placental growth factors: new players in the slow relaxin vasodilatory pathway. 5th International Converence on Relaxin and Related Peptides May 18-23, 2008, Maui, HI.